- Diagnostic Code
- 7718
- CFR Section
- §4.117 — Hemic & Lymphatic
Rating Tiers
100%
Requiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments: peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment
70%
Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 × 10/L[9]
30%
Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count of 200,000-400,000, or white blood cell (WBC) count of 4,000-10,000
What Raters Look For
Based on M21-1 adjudication criteria for Hemic & Lymphatic conditions. These are the factors a VA rater evaluates when assigning a rating percentage.
M21-1 III.iv.4.G- •Complete blood count (CBC) values: hemoglobin, platelet count, white cell count
- •Whether transfusions are required and how frequently
- •Bone marrow biopsy or transplant history
- •Response to treatment and current treatment regimen
- •Constitutional symptoms: fatigue, weight loss, fever